Phase 2 Limited Stage Small Cell Lung Cancer Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 2
Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
Limited Stage Small Cell Lung CancerThoracic NeoplasmsRespiratory Tract Neoplasms+1 more
Fundación GECP37 enrolled20 locationsNCT07242547
Recruiting
Phase 2
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
SCLCSmall Cell Lung CancerLimited Stage Small Cell Lung Cancer+1 more
Hirva Mamdani84 enrolled4 locationsNCT05903092
Recruiting
Phase 2
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
SCRI Development Innovations, LLC250 enrolled33 locationsNCT06773910
Recruiting
Phase 2
Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)
Limited Stage Small Cell Lung Cancer
Fudan University60 enrolled1 locationNCT06943235
Recruiting
Phase 2
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial
Limited Stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China30 enrolled1 locationNCT06256237
Recruiting
Phase 2
Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients
Limited Stage Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences55 enrolled2 locationsNCT05443646
Recruiting
Phase 2Phase 3
Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT
Limited Stage Small Cell Lung Cancer
Sun Yat-sen University346 enrolled1 locationNCT05623267
Completed
Phase 2
Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease
Small Cell Lung CancerLimited Stage Small Cell Lung Cancer
NHMRC Clinical Trials Centre50 enrolled20 locationsACTRN12618000918224